Skip to main content
SpringerLink
Log in

Wann ist der Einsatz der Skalphypothermie wirklich sinnvoll?

  • Conference paper
Unterstützende Pflege bei Krebspatienten

  • 30 Accesses

Zusammenfassung

Haarverlust ist eine häufige Nebenwirkung der medikamentösen Tumortherapie. Verschiedene Zytostatika wie Adriamycin, Cyclophosphamid, Etoposid und die Vincaalkaloide führen zu schwerem Haarausfall. Für viele Patienten bedeutet der chemotherapiebedingte Haarverlust eine schwerwiegende Beeinträchtigung ihres Selbstwertgefühls.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anderson JE, Hunt JM, Smith IE (1981) Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer. Br Med J 282: 423–424

    Article  CAS  Google Scholar 

  2. Belpomme D, Mignot L, Grandjean M, Pujade-Lauraine E (1982) Préventation de l’alopécie des chimiothérapies anticancéreuses par hypothermie du cuir chevelu. Nouv Presse Med 11: 929–931

    PubMed  CAS  Google Scholar 

  3. Dean JC, Salmon SE, Griffith KS (1979) Prevention of doxorubicin-induced hair loss with scalp hypothermia. N Engl J Med 301: 1427–1429

    Article  PubMed  CAS  Google Scholar 

  4. Dean JC, Salmon SE, Griffith KS, Cetas TC, Mackel C (1981) Scalp hypothermia: A comparison of ice packs and Kold Kap in the prevention of adriamycin ( ADR) induced alopecia. Proc ASCO 22: 415

    Google Scholar 

  5. Edelstyn GA, MacDonald M, MacRae KD (1977) Doxorubicin-induced hair loss and possible modification by scalp cooling. Lancet II: 253–254

    Google Scholar 

  6. Goldhirsch A, Kiser J, Brunner KW (1982) Verhinderung des zytostatikabedingten Haaraus-falles durch Hypothermie der behaarten Kopfhaut mittels einer Kühlklappe. Schweiz Med Wochenschr 112: 568–571

    PubMed  CAS  Google Scholar 

  7. Grandjean M, Belpomme D, Pujade LE, Marty M, Boiron M (1980) Prevention of drug-induced alopecia in cancer patients. Cancer Chemother Pharmacol 5: 22

    Google Scholar 

  8. Gregory RP, Cooke T, Middleton J (1982) Prevention of doxorubicin-induced alopecia by scalp hypothermia: Relation to degree of cooling. Br Med J 284: 1674

    Google Scholar 

  9. Guy R, Parker H, Shah S, Geddes D (1982) Scalp cooling by thermocirculator. Lancet 1: 78

    Google Scholar 

  10. Hunt JM, Anderson JE, Smith IE (1982) Scalp hypothermia to prevent adriamycin-induced hair loss. Cancer Nurs 5: 25–31

    Article  PubMed  CAS  Google Scholar 

  11. Kiser J, Jungi E, Salchli S (1982) Kopfhautkühlung zur Verhütung des zytostatika-bedingten Haarausfalles. Z Krankenpflege SBK 12: 29–32

    Google Scholar 

  12. Luce JK, Raffetto TJ, Crisp MJ, Grief GC (1973) Prevention of alopecia by scalp cooling of patients receiving adriamycin. Cancer Chemother Rep 57: 108–109

    Google Scholar 

  13. Pesce A, Cassuto JP, Joyner MV, Du Jardin P, Audoly P (1978) Scalp tourniquet in the prevention of chemotherapy-induced alopecia. N Engl J Med 298: 1204–1205

    PubMed  CAS  Google Scholar 

  14. Witman G, Cadman E, Chen M (1981) Misuse of scalp hypothermia. Cancer Treat Rep 65: 507–508

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Josy Kiser
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik C, Kantonsspital St. Gallen, CH-9007, St. Gallen, Switzerland

    Agnes Glaus (Oberschwester) & Hans-Jörg Senn (Oberschwester) & 

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kiser, J. (1988). Wann ist der Einsatz der Skalphypothermie wirklich sinnvoll?. In: Glaus, A., Senn, HJ. (eds) Unterstützende Pflege bei Krebspatienten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-88574-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-88574-7_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-17151-5

  • Online ISBN: 978-3-642-88574-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation